Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

80.47
Delayed Data
As of Jun 24
 -2.90 / -3.48%
Today’s Change
80.22
Today|||52-Week Range
123.37
-20.48%
Year-to-Date
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
The 3 Most Important Data Releases and FDA Decisions in the Second Half of 2016
Jun 23 / MotleyFool.com - Paid Partner Content
Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU
Jun 24 / Zacks.com - Paid Partner Content
Share Buybacks Rise to Record Level in First Quarter
Jun 22 / GuruFocus News - Paid Partner Content
Gilead (GILD) Weak In Early Morning Trading
Jun 24 / TheStreet.com - Paid Partner Content
Gilead Downside Is Path of Least Resistance
Jun 22 / TheStreet.com - Paid Partner Content
Corporate Share Buybacks Rise to Record Level in First Quarter
Jun 23 / GuruFocus News - Paid Partner Content
Biotech Stocks Rally on Medicare Cost-Cutting Stand Down
Jun 22 / TheStreet.com - Paid Partner Content
Uh-oh. Is the stock market a bubble again?
Jun 23 / CNNMoney.com
Stock Market News for June 22, 2016
Jun 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close83.37
Today’s open81.17
Day’s range80.22 - 82.25
Volume12,201,746
Average volume (3 months)10,375,905
Market cap$111.0B
Dividend yield2.34%
Data as of 3:59pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-4.21%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)+28.71%
P/E ratio6.9
Price/Sales4.80
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-5.82-3.82%
BIIBBiogen-9.60-4.02%
BAXBaxter International...-2.11-4.59%
JUNOJuno Therapeutics In...-3.25-7.44%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$2.99
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs